tirzepatide cv outcomes linked to lower risk for death, adverse and kidney vs. GLP-1s tirzepatide cardiovascular outcomes trial results

Hyperpigmentation Reduction : Kojic Acid Dipalmitate helps to make dark spots, age spots, and other forms of hyperpigmentation look less noticeable

Sublingual B12 has better absorption than oral tablets, especially if you have any GI problems

Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials

Treatment with tirzepatide resulted in a mean increase in heart rate of 14, 24 and 36 beats per minute (bpm) for 5-, 10- and 15-mg groups, respectively, at the end of study treatment (Week 40/42 for SURPASS-1, 2 and 5 and Week 52 for SURPASS-3 and 4)

This dual mechanism is one reason peptide therapy is being explored more aggressively in men who do not respond adequately to first-line treatments